← Pepstar
What podcasts say about Pepstar
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Pepstar
1 statement · 1 neutral
Pepstar’s oral IL-23 inhibitor lacked efficacy data and was in phase one testing.
“this is in, as I said, a phase one trial in healthy volunteers. We don't have any efficacy data”
Open the episode · Ep. 394 - Security concerns in U.S., China reshaping biotechListen at 20:06
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.